J&J Gives Up On Botox Rival

J&J announced last week that it will abandon efforts to bring to market a rival drug to Allergan's popular anti-wrinkle treatment, Botox.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news